HMHB.org is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. Additionally, HMHB.org participates in various other affiliate programs, and we sometimes get a commission through purchases made through our links.
Another marker of obesity and diabetes includes damage to liver cells. The liver is a major organ in the conversion between stored energy forms and useable energy forms in the body. Overburdening that system, such as with high fructose intake, can have disastrous effects. Inflammation within the liver indicates the onset of dysfunction, and possibly non-alcoholic fatty liver disease.
Hemplucid uses domestically sourced full-spectrum CBD to make this tincture. It includes a medium-chain triglyceride carrier MCT oil as part of the formula. This product contains terpenes and nearly undetectable levels of THC. The ingredients are all-natural, and they come from hemp plants that are bred for almost ten years to ensure a high level of cannabinoids. This product is certified as organic, and it does not contain GMOs.
It’s important to remember, though, that these areas of study are still very new and in their early stages. This makes it hard to predict just how far their reach and impact will be. Combined with lifestyle and dietary changes, prescribed cannabinoid use will very likely be a pivotal intervention in the future of obesity and diabetes management and recovery.
He did exhaustive research. He found there’d been decades of scientific studies on the effects of THC and CBD on cells and animals, but few trials with humans, because the FDA classifies cannabis and all its components as Schedule 1 drugs, which have “no accepted medical treatment use.” It took Sue Sisley, an Arizona physician, seven years of struggling with bureaucratic hurdles before she received the first FDA approval for a study, just beginning, of marijuana with vets who have PTSD.
Recent evidence from animal and human studies shows a role for the endocannabinoid system in maintaining energy balance and glucose as well as lipoprotein metabolism, according to a 2009 study. Modulation of this system has resulted in an improvement in a number of important risk factors in clinical trials, including visceral and subcutaneous abdominal adipose tissue, glucose tolerance, dyslipidemia and measures of inflammation.
Cheanné is a freelance writer and blogger. She writes primarily about nutrition, fitness, and mental health. She has diplomas in Personal Nutrition and Weight Loss from Shaw Academy and an Introductory Certificate in Exercise Science from the Health and Fitness Professionals Academy (HFPA). She is also a qualified group fitness instructor. When not writing, she enjoys jamming on her guitar, reading, eating good food, trips to the beach, hiking, and spending time with her family and friends.